Liver transplantation in glycogen storage disease type III: A case‐series
Abstract Glycogen storage disease type III (GSD III) is a rare metabolic disorder characterized by a deficiency of liver and muscle amylo‐1,6‐glucosidase. This condition presents with severe hepatic symptoms in childhood, mostly hepatomegaly, hypoglycemia in half of patients, while muscular complica...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | JIMD Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jmd2.12463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583743287590912 |
|---|---|
| author | Simon Gay Adrien Bigot Louis d'Alteroche Fanny Dujardin Gaëlle Fromont‐Hankard Nathalie Tressel Ephrem Salame François Maillot |
| author_facet | Simon Gay Adrien Bigot Louis d'Alteroche Fanny Dujardin Gaëlle Fromont‐Hankard Nathalie Tressel Ephrem Salame François Maillot |
| author_sort | Simon Gay |
| collection | DOAJ |
| description | Abstract Glycogen storage disease type III (GSD III) is a rare metabolic disorder characterized by a deficiency of liver and muscle amylo‐1,6‐glucosidase. This condition presents with severe hepatic symptoms in childhood, mostly hepatomegaly, hypoglycemia in half of patients, while muscular complications may predominate in adulthood. Hepatic fibrosis, cirrhosis and hepatocellular carcinoma (HCC) are common complications in older patients. Therefore, regular monitoring, including HCC screening, is essential for effective disease management. In some severe cases, liver transplantation (LT) may be necessary to treat life‐threatening complications. Here, we report the cases of three adult patients who required LT during the course of GSD III. Case #1: Diagnosis of GSD III was made in childhood, with development of hepatocellular carcinoma requiring partial hepatectomy followed by LT due to post‐operative complications. The patient recovered well and had favorable surveillance over a seven‐year period. Case #2: Diagnosis of GSD III in early childhood, with progression to cirrhosis in adulthood. Severe hepatic encephalopathy necessitated urgent transplantation, with a favorable recovery, although muscular symptoms remained present. Case #3: Diagnosis of GSD III in childhood, followed by later development of hepatocellular adenocarcinoma requiring LT. The patient recovered well and did not exhibit post‐transplant muscular symptoms. Post‐LT outcome was positive for all three GSD III patients, with significant improvement in liver function and no complications related to immunosuppression. Long‐term hepatic monitoring is essential for early detection of complications such as cirrhosis and HCC. LT indications should be individually evaluated, preferring less invasive options. These cases highlight the importance of a multidisciplinary approach to the effective management of GSD III, with particular attention to hepatic and muscular surveillance. |
| format | Article |
| id | doaj-art-c9f1c7d54dc04d6d98b6b8e5ee919590 |
| institution | Kabale University |
| issn | 2192-8312 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | JIMD Reports |
| spelling | doaj-art-c9f1c7d54dc04d6d98b6b8e5ee9195902025-01-28T07:38:32ZengWileyJIMD Reports2192-83122025-01-01661n/an/a10.1002/jmd2.12463Liver transplantation in glycogen storage disease type III: A case‐seriesSimon Gay0Adrien Bigot1Louis d'Alteroche2Fanny Dujardin3Gaëlle Fromont‐Hankard4Nathalie Tressel5Ephrem Salame6François Maillot7Internal Medicine Department Tours Hospital Tours FranceInternal Medicine Department Tours Hospital Tours FranceHepatology Department Tours Hospital Tours FrancePathological Department Pathological Department Tours Hospital Tours FranceTours University Tours FranceInternal Medicine Department Tours Hospital Tours FranceTours University Tours FranceInternal Medicine Department Tours Hospital Tours FranceAbstract Glycogen storage disease type III (GSD III) is a rare metabolic disorder characterized by a deficiency of liver and muscle amylo‐1,6‐glucosidase. This condition presents with severe hepatic symptoms in childhood, mostly hepatomegaly, hypoglycemia in half of patients, while muscular complications may predominate in adulthood. Hepatic fibrosis, cirrhosis and hepatocellular carcinoma (HCC) are common complications in older patients. Therefore, regular monitoring, including HCC screening, is essential for effective disease management. In some severe cases, liver transplantation (LT) may be necessary to treat life‐threatening complications. Here, we report the cases of three adult patients who required LT during the course of GSD III. Case #1: Diagnosis of GSD III was made in childhood, with development of hepatocellular carcinoma requiring partial hepatectomy followed by LT due to post‐operative complications. The patient recovered well and had favorable surveillance over a seven‐year period. Case #2: Diagnosis of GSD III in early childhood, with progression to cirrhosis in adulthood. Severe hepatic encephalopathy necessitated urgent transplantation, with a favorable recovery, although muscular symptoms remained present. Case #3: Diagnosis of GSD III in childhood, followed by later development of hepatocellular adenocarcinoma requiring LT. The patient recovered well and did not exhibit post‐transplant muscular symptoms. Post‐LT outcome was positive for all three GSD III patients, with significant improvement in liver function and no complications related to immunosuppression. Long‐term hepatic monitoring is essential for early detection of complications such as cirrhosis and HCC. LT indications should be individually evaluated, preferring less invasive options. These cases highlight the importance of a multidisciplinary approach to the effective management of GSD III, with particular attention to hepatic and muscular surveillance.https://doi.org/10.1002/jmd2.12463case‐seriesglycogen storage diseaselivertransplantation |
| spellingShingle | Simon Gay Adrien Bigot Louis d'Alteroche Fanny Dujardin Gaëlle Fromont‐Hankard Nathalie Tressel Ephrem Salame François Maillot Liver transplantation in glycogen storage disease type III: A case‐series JIMD Reports case‐series glycogen storage disease liver transplantation |
| title | Liver transplantation in glycogen storage disease type III: A case‐series |
| title_full | Liver transplantation in glycogen storage disease type III: A case‐series |
| title_fullStr | Liver transplantation in glycogen storage disease type III: A case‐series |
| title_full_unstemmed | Liver transplantation in glycogen storage disease type III: A case‐series |
| title_short | Liver transplantation in glycogen storage disease type III: A case‐series |
| title_sort | liver transplantation in glycogen storage disease type iii a case series |
| topic | case‐series glycogen storage disease liver transplantation |
| url | https://doi.org/10.1002/jmd2.12463 |
| work_keys_str_mv | AT simongay livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT adrienbigot livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT louisdalteroche livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT fannydujardin livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT gaellefromonthankard livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT nathalietressel livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT ephremsalame livertransplantationinglycogenstoragediseasetypeiiiacaseseries AT francoismaillot livertransplantationinglycogenstoragediseasetypeiiiacaseseries |